These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 2139286
1. Comparison of a recombinant DNA hepatitis B vaccine alone or in combination with hepatitis B immune globulin for the prevention of perinatal acquisition of hepatitis B carriage. Poovorawan Y, Sanpavat S, Pongpunlert W, Chumdermpadetsuk S, Sentrakul P, Chitinand S, Sakulramrung R, Tannirundorn Y. Vaccine; 1990 Mar; 8 Suppl():S56-9; discussion S60-2. PubMed ID: 2139286 [Abstract] [Full Text] [Related]
2. Anti-HBs levels in infants of hepatitis B carrier mothers after delayed active immunization with recombinant vaccine concomitant with DTP-polio vaccine: is there need for a second dose of HBIg? Dutch Study Group on Prevention of Neonatal Hepatitis B. Grosheide PM, del Canho R, Voogd M, Heijtink RA, Schalm SW. Vaccine; 1994 Sep; 12(12):1059-63. PubMed ID: 7998413 [Abstract] [Full Text] [Related]
3. An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China. Halliday ML, Kang LY, Rankin JG, Coates RA, Corey PN, Hu ZH, Zhou TK, Yuan GJ, Yao FL. Int J Epidemiol; 1992 Jun; 21(3):564-73. PubMed ID: 1386063 [Abstract] [Full Text] [Related]
4. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study. Wong VC, Ip HM, Reesink HW, Lelie PN, Reerink-Brongers EE, Yeung CY, Ma HK. Lancet; 1984 Apr 28; 1(8383):921-6. PubMed ID: 6143868 [Abstract] [Full Text] [Related]
6. Combined passive and active immunization for interruption of perinatal transmission of hepatitis B virus in Taiwan. Lo KJ, Tsai YT, Lee SD, Yeh CL, Wang JY, Chiang BN, Wu TC, Yeh PS, Goudeau A, Coursaget P. Hepatogastroenterology; 1985 Apr 28; 32(2):65-8. PubMed ID: 3159639 [Abstract] [Full Text] [Related]
8. Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers. Lo KJ, Tsai YT, Lee SD, Wu TC, Wang JY, Chen GH, Yeh CL, Chiang BN, Yeh SH, Goudeau A. J Infect Dis; 1985 Oct 28; 152(4):817-22. PubMed ID: 2931490 [Abstract] [Full Text] [Related]
10. Efficacy of hepatitis-B immunoglobulin and hepatitis-B vaccine in prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg. Pongpipat D, Suvatte V, Assateerawatts A. Asian Pac J Allergy Immunol; 1986 Jun 28; 4(1):33-6. PubMed ID: 3730058 [Abstract] [Full Text] [Related]
11. A combination of hepatitis B vaccine and immunoglobulin does not protect all infants born to hepatitis B e antigen positive mothers. Farmer K, Gunn T, Woodfield DG. N Z Med J; 1987 Jul 08; 100(827):412-4. PubMed ID: 2967932 [Abstract] [Full Text] [Related]
13. Prevention of perinatal transmission of hepatitis B virus (HBV) to children of e antigen-positive HBV carrier mothers by hepatitis B immune globulin and HBV vaccine. Kanai K, Takehiro A, Noto H, Nishida M, Takahashi K, Kawashima Y, Igarashi Y, Matsushita K, Shimizu M. J Infect Dis; 1985 Feb 08; 151(2):287-90. PubMed ID: 3155779 [Abstract] [Full Text] [Related]
14. Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers. Poovorawan Y, Sanpavat S, Pongpunlert W, Chumdermpadetsuk S, Sentrakul P, Safary A. JAMA; 1989 Jun 09; 261(22):3278-81. PubMed ID: 2523981 [Abstract] [Full Text] [Related]
19. Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. Stevens CE, Taylor PE, Tong MJ, Toy PT, Vyas GN, Nair PV, Weissman JY, Krugman S. JAMA; 1987 May 15; 257(19):2612-6. PubMed ID: 2952812 [Abstract] [Full Text] [Related]